J, M., AR, M., H, K., R, B., J, P., A, K., . . . R, H. (2023). A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis. Clinical cancer research : an official journal of the American Association for Cancer Research, 29(18), 3622. https://doi.org/10.1158/1078-0432.CCR-23-0276
Chicago Style (17th ed.) CitationJ, Mascarenhas, et al. "A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 29, no. 18 (2023): 3622. https://doi.org/10.1158/1078-0432.CCR-23-0276.
MLA (9th ed.) CitationJ, Mascarenhas, et al. "A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 29, no. 18, 2023, p. 3622, https://doi.org/10.1158/1078-0432.CCR-23-0276.